Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2003
12/23/2003US6667342 Benzenesulfonamide-derivatives and their use as medicaments
12/23/2003US6667339 Contraceptive
12/23/2003US6667337 Combination therapy for cancer
12/23/2003US6667336 Phenyl-thienyl-prop-1-en-3-yl-sarcosine derivatives; nontoxic; neurological and neuropsychiatric disorders; glycine transporter sequestering
12/23/2003US6667335 NMDA (N-methyl-D-aspartate)-receptor subtype selective blockers
12/23/2003US6667334 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
12/23/2003US6667332 Benzisoxazolyl-pyrazole derivatives formed by salt formation with maleic acid and hydrochloric acid and cyclization with acetohydroxamic acid
12/23/2003US6667331 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/23/2003US6667330 Cytoprotective; neuroinflammation and neurodegenerative disorders; oxidative stress related conditions
12/23/2003US6667329 Agents with antidepressant action, containing pramipexol and second antidepressant
12/23/2003US6667328 Such as 2-(N-Cyanoimino)-5-((E)-4-styrylbenzylidene)thiazol-idin-4-one; prophylaxis of hypolipidemic/hypoglycemic, hyper-/hypo-cholesterolemia activity
12/23/2003US6667327 Pyridine amido derivatives
12/23/2003US6667325 P38MAP kinase inhibiters; tumor necrosis factor alpha, interleukin 1 and 6 and cyclooxygenase II related diseases
12/23/2003US6667324 Dry blend pharmaceutical formulations
12/23/2003US6667323 Dry-blend pharmaceutical formulations
12/23/2003US6667322 Useful for treatment of diseases such as obsessive compulsive disorder, panic attacks, anxiety, sexual dysfunction, eating disorders, obesity, addictive disorders
12/23/2003US6667321 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
12/23/2003US6667320 For therapy of infalmmation; asthma, cancer, arthritis, multiple sclerosis; prophylaxis of infection of target cells by a human immunodeficiency virus (HIV)
12/23/2003US6667319 Neuropeptide Y Y5 receptor antagonists
12/23/2003US6667318 LFA-1 antagonist compounds
12/23/2003US6667317 Pharmaceutical combinations for the treatment of stroke and traumatic brain injury
12/23/2003US6667316 Pharmaceutically active isoindoline derivatives
12/23/2003US6667315 Pyridoxine phosphonate analogues such as, for example, ((2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)alkylphosphonates, and (2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)azaalkylphosphonates)
12/23/2003US6667314 Tropane derivatives useful in therapy
12/23/2003US6667313 8-substituted-6-triflouromethyl-9-pyrido [3,2-G] quinoline compounds as androgen receptor modulators
12/23/2003US6667312 Thioether substituted imidazoquinolines
12/23/2003US6667305 Alzheimer's disease; beta-amyloid peptide is a small fragment of the amyloid precursor protein
12/23/2003US6667304 Affinity for melatonin receptors; sleep disorders; N-(2-(2-methoxy-6H-pyrido(2',3':4,5)pyrrolo(2,1-a)isoindol-11 -yl)ethyl)acetamide; N-(2-(3-methoxy-6,7,8,9-tetrahydropyrido (3,2-b)indolizin-5-yl) ethyl)acetamide
12/23/2003US6667302 Heterocyclic topoisomerase poisons
12/23/2003US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
12/23/2003US6667300 Purinyl substituted quinazoline-4-one derivatives
12/23/2003US6667299 16-alpha-bromo-3-beta-hydroxy-5-alpha-androstan-17-one hemihydrate; 16-alpha-bromoepiandrosterone; steroid; immune modulator
12/23/2003US6667298 26,27-Homologated-20-EPI-2-alkyl-19-NOR-vitamin D compounds
12/23/2003US6667297 Methods for treating neuropsychiatric disorders
12/23/2003US6667296 Method for preventing and reducing radiation cystitis using hyaluronic acid
12/23/2003US6667295 DNA vaccine against feline immunodeficiency virus
12/23/2003US6667294 Freeze drying aqueous solution
12/23/2003US6667293 Of certain phosphorothioate antisense oligonucleotides used to treat pathogenic infections, cancer, and inherited conditions
12/23/2003US6667292 Metabolite is an s-nitroso-low molecular weight thiol compound, s-nitrosoglutathione; blood substitutes and organ perfusion solutions
12/23/2003US6667064 Composition and method for treatment of hypertriglyceridemia
12/23/2003US6667061 Microparticles comprising polymeric binder and injection vehicle, wherein microparticles are suspended in vehicle at concentration of greater than 30 mg/ml to form suspension having viscosity of 600 cp at 20 degrees C
12/23/2003US6667060 Pregelatinized starch in a controlled release formulation
12/23/2003US6667058 Oral forms of administration containing solid flupirtine with controlled release of active substance
12/23/2003US6667057 At least three dosages forms, each of which has a different release profile, with the Cmax for the antibiotic product being reached in less than about twelve hours.
12/23/2003US6667054 Metformin hydrochloride tablets
12/23/2003US6667053 D and L etherlipid stereoisomers and liposomes
12/23/2003US6667050 Chewable oral contraceptive
12/23/2003US6667048 Pharmaceutical composition comprising taxoid, taxane or taxine as chemotherapeutic agent, alpha-tocopherol, tocopherol polyethylene glycol succinate, and aqueous phase, in form of emulsion or microemulsion with drug in oil phase
12/23/2003US6667043 Technical di- and triglyceride mixtures
12/23/2003US6667042 Ciprofloxacin administered in three dosages forms with different release profiles; Cmax is reached in < about twelve hours
12/23/2003US6667041 Use of neurotoxin therapy for treatment of urologic and related disorders
12/23/2003US6667029 Stable, aqueous cationic hydrogel
12/23/2003US6667028 Hair growth promoter
12/23/2003US6667026 Allergic contact dermatitis treatment and composition therefor
12/23/2003US6667025 Compositions and methods of using compositions with accelerated lymphocyte homing immunosuppressive properties
12/23/2003US6667024 Kit comprising molecule with radioisotope binding site linked to antigen-binding fragment of antibody that specifically binds to tumor associated antigen, and metal chelator and basic amino acid or peptide clearing agents
12/23/2003CA2323211C Topical anesthetic formulation
12/23/2003CA2307080C Process for preparing 8-cyclopentyl-6-ethyl-3-¬substituted|-5,8-dihydro-4h-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
12/23/2003CA2302232C Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent
12/23/2003CA2294251C Satiety product
12/23/2003CA2268439C Citrus peel extract as 3-hydroxy-3-methylglutaryl coa(hmg-coa) reductase inhibitor
12/23/2003CA2267800C Tricyclic compounds having activity as ras-fpt inhibitors
12/23/2003CA2265983C Therapeutic use of d-methionine to reduce the toxicity of platinum-containing anti-tumor compounds
12/23/2003CA2233178C (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/23/2003CA2223643C Sustained-release formulation of d-threo-methylphenidate
12/23/2003CA2147172C Transdermal therapeutic system for the release of 17-.beta.-estradiol and process for its production
12/23/2003CA2116387C Oxazolidinedione derivatives, their production and use
12/23/2003CA2087084C Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antimycotic activity
12/23/2003CA2059063C Novel antiviral compounds
12/19/2003WO2002101076A2 Methods for targeted expression of therapeutic nucleic acid
12/19/2003CA2460095A1 Methods for targeted expression of therapeutic nucleic acid
12/18/2003WO2003104495A1 METHODS FOR BLOCKING ADIPOCYTE DIFFERENTIATION AND TRIGLYCERIDE ACCUMULATION WITH INTERLEUKIN 12 p35 INHIBITORS
12/18/2003WO2003104482A1 Signals and molecular species involved in senescence
12/18/2003WO2003104475A2 Atm related kinase atx, nucleic acids encoding same and methods of use
12/18/2003WO2003104473A2 Galactosyl isomalt, method for production and use thereof
12/18/2003WO2003104416A2 Spliceosome mediated rna trans-splicing in stem cells
12/18/2003WO2003104396A2 Control of protozoa and protonzoan cysts that harbor legionella
12/18/2003WO2003104282A2 Immunoadhesin comprising a glycoprotein vi domain
12/18/2003WO2003104257A2 Protease inhibitors
12/18/2003WO2003104256A2 THE CaR RECEPTOR AS A MEDIATOR OF MIGRATORY CELL CHEMOTAXIS AND/OR CHEMOKINESIS
12/18/2003WO2003104255A2 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
12/18/2003WO2003104254A2 Novel derivatives of androstane and androstene with ascorbic a cid and use thereof in treating or preventing various conditions, diseases, and disorders
12/18/2003WO2003104253A2 9-alpha-substituted estratrienes as selectively active estrogen
12/18/2003WO2003104250A1 New compounds for modulating the activity of exchange proteins directly activated by camp (epacs)
12/18/2003WO2003104246A1 Carbacyclic phosphatidic acid derivative
12/18/2003WO2003104238A1 Novel compound having antitumor activity and process for producing the same
12/18/2003WO2003104236A1 Calcitonin gene related peptide receptor antagonists
12/18/2003WO2003104235A1 Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]pyrazines and decahydropyrazino[1,2-a]azepines
12/18/2003WO2003104229A1 Novel fused imidazole derivative
12/18/2003WO2003104228A1 Use of benzo[c]quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction
12/18/2003WO2003104227A1 2-heteroaryl carboxamides
12/18/2003WO2003104226A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
12/18/2003WO2003104225A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
12/18/2003WO2003104223A1 Pyrazole-derivatives as p38 kinase inhibitors
12/18/2003WO2003104222A1 Bisindolyl-maleimid derivatives as kinase inhibitors
12/18/2003WO2003104221A1 Inhibitors of the gpib -vwf interaction, their preparation and use
12/18/2003WO2003104219A1 Nf-kb inhibitors
12/18/2003WO2003104218A1 Nf-:b inhibitors
12/18/2003WO2003104217A2 Prodrugs of excitatory amino acids
12/18/2003WO2003104213A1 Preparation process of biphenylcarboxylic acid amide derivatives
1 ... 5236 5237 5238 5239 5240 5241 5242 5243 5244 5245 5246 5247 5248 5249 5250 5251 5252 5253 5254 5255 5256 ... 7860